Psyence Biomedical Ltd.
PBMWW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001985062
No open-market purchases or sales by Psyence Biomedical Ltd. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $121.6K in total; no superinvestor holds it.
Other share classesPBM
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, 0 vs. previous quarter
- 19
- 13F valueReported value at the end of Q2 2026
- $121.6K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding PBMWW, Q2 2026
No superinvestor reported holding PBMWW at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Psyence Biomedical Ltd. insiders from Form 4, newest first.
No open-market purchases or sales by Psyence Biomedical Ltd. insiders are on file.
Top 10 13F holders, Q2 2026
The largest institutional positions in Psyence Biomedical Ltd. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Harraden Circle Investments, LLC | 1,149,000 | $27.9K | 0.00% | −1,000−0.1% | Reduced |
| Polar Asset Management Partners Inc. | 733,000 | $16.6K | 0.00% | 00.0% | Unchanged |
| MMCAP International Inc. SPC | 600,000 | $14.6K | 0.00% | 00.0% | Unchanged |
| Toronto Dominion Bank | 503,012 | $12.1K | 0.00% | −300−0.1% | Reduced |
| Calamos Advisors LLC | 500,000 | $10.5K | 0.00% | 00.0% | Unchanged |
| Saba Capital Management, L.P. | 297,847 | $7.24K | 0.00% | 00.0% | Unchanged |
| Clear Street Group Inc. | 257,202 | $6.25K | 0.00% | −70.0% | Reduced |
| Goldman Sachs Group Inc | 200,117 | $4.86K | 0.00% | 00.0% | Unchanged |
| LMR Partners LLP | 200,000 | $4.86K | 0.00% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 175,352 | $3.68K | 0.00% | 00.0% | Unchanged |